-
This is not the time to undermine harm reduction strategies such as the needle exchange programme, bravely, and surprisingly, initiated by Thatcher and her Tory government.
18 June 2013 | The Guardian
-
While the results of the Bangkok Tenofovir Study are striking, so is the difficulty of assessing the relevance of these clinical trial results for most of the world.
17 June 2013 | Huffington Post
-
Malaysia has taken great strides in tackling HIV - needle exchange has been widely accepted by Islamic leaders as a necessity to preserve life. However, there are more delicate issues surrounding HIV prevention including the use of condoms outside of marriage, especially by men who have sex with men and sex workers.
61229-5/fulltext)
14 June 2013 | The Lancet
-
Over 500 organizations and individuals from nearly 60 countries have endorsed a Global Call to Action on Lubricant Safety. They all demand answers on whether sexual lubricants are safe for vaginal and anal intercourse. As the Call to Action points out, there are more questions than answers about the safety of sexual lubricants, and there are concerns that some of the products available on store shelves and at community-based organizations worldwide may actually cause harm.
)
13 June 2013 | IRMA - Rectal Microbicide Advocacy
-
Activists complain of a “regression” in Brazil’s anti-HIV/AIDS strategy, which was considered one of the boldest and most effective in the world. A controversial campaign for sex workers has been cancelled and the head of the HIV program fired, under pressure from conservative evangelical churches.
13 June 2013 | Inter Press Service
-
"This is the first trial to provide evidence for a prevention option that could protect against HIV infection through both sexual contact and injecting drug use—and this is an exciting finding that must be followed up. PrEP could be a powerful additional tool for some people who inject drugs,” said Mitchell Warren, AVAC executive director.
13 June 2013 | AVAC press release
-
A daily dose of a medication used to treat HIV infection reduced the risk of HIV acquisition among people who inject drugs by 49 percent. Those who took the medication most consistently had even higher levels of protection, according to a new study announced today by the Centers for Disease Control and Prevention – in collaboration with the Bangkok Metropolitan Administration (BMA) and the Thailand Ministry of Public Health (MOPH).
13 June 2013 | CDC press release
-
News and interviews on harm reduction and injecting drug use from the 2013 International Harm Reduction Conference in Vilnius, Lithuania.
12 June 2013 | International Harm Reduction Conference Daily Update
-
"Funding allocation -- be it governmental or private -- largely does not address stigma, shame and denial...the community is wandering around in ignorance about the availability of treatment and the ability to live a normal life with HIV infection." CDC scientist argues for better linkage to care and campaigns to improve HIV literacy.
12 June 2013 | The Body Pro
-
Studies have reported HIV superinfection incidence rates of between 0 and 7.7 percent per year, but understanding of the phenomenon is hazy.
10 June 2013 | AIDSMeds
Get set for HIV treatmentA tool to help you decide whether you are ready to start taking HIV treatment.
HIV, GPs & other primary careThis booklet explains the services GPs offer, how this fits with HIV specialist care, and how to make the most of primary care services.
NAM is the official provider of online scientific news for IAS 2013 18 June 2013The 7th
International AIDS Society Conference on HIV Pathogenesis, Treatment and
Prevention...
Impact of switching to generic drugs in the UK – survey results 11 June 2013A recent NAM survey shows that people living with HIV...
HIV cure research – free webinar 28 May 2013As part of its European HIV prevention work, NAM is
collaborating...